RMD vs SYK: fair value comparison
ResMed Inc. and Stryker Corporation · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, SYK currently sits closer to the top of our discount ranking.
| RMD | SYK | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $228.35 | $303.13 |
| 12-month range | $186.44–$257.39 | $294.73–$387.02 |
| Sector rank | #24 of 113 Healthcare | #21 of 113 Healthcare |
| Quality grade | A | A |
| Momentum grade | B | — |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Oversold |
| DCF cross-check | Fairly Valued | Overvalued |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: RMD fair value analysis · SYK fair value analysis